Business Context and Reporting Period
Company: Albemarle Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1996
Business Overview: Following the sale of its alpha olefins, poly alpha olefins, and synthetic alcohol businesses ("Olefins Business") to Amoco Chemical Company on March 1, 1996, Albemarle is now focused on bromine chemicals, specialty chemicals, and detergents and surfactants.
Key Financial Metrics
| Metric (in thousands) | Q1 1996 | Q1 1995 |
|---|---|---|
| Net Sales | $270,171 | $313,257 |
| Gross Profit | $74,111 | $66,931 |
| Gross Margin | 27.4% | 21.4% |
| Operating Profit | $33,440 | $28,987 |
| Net Income | $115,624 | $14,608 |
| Earnings Per Share | $1.73 | $0.22 |
| Cash and Equivalents (End of Period) | $329,693 | $31,495 |
| Long-Term Debt (Total) | $9,710 | $217,112 |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 14% to $270.2 million, primarily due to the sale of the Olefins Business on March 1, 1996, resulting in only two months of revenue from that segment compared to three months in 1995. Excluding sold businesses, underlying sales increased 3%.
- Profit Surge: Net income increased significantly to $115.6 million from $14.6 million. This is driven by a one-time gain on sale of business of $158.2 million (pre-tax) from the Amoco transaction.
- Margin Expansion: Gross profit margin improved to 27.4% from 21.4%, aided by lower raw material prices and the exit of lower-margin olefins operations.
- Debt Reduction: Long-term debt plummeted from $217.1 million to $9.7 million as proceeds from the business sale were used to repay borrowings. Debt-to-total capitalization dropped to 1.3%.
- Liquidity Increase: Cash and cash equivalents rose by $296.6 million to $329.7 million, reflecting the $510 million net proceeds from the asset sale.
Guidance, Outlook, and Risks
- Capital Allocation: The Company utilized sale proceeds to repay debt and fund a share repurchase program. On April 1, 1996, Albemarle purchased 9.5 million shares (approx. 14.3% of outstanding stock) at $23 per share.
- Future Outlook: Management anticipates cash flow from operations will be sufficient to cover expenses, debt service, and dividends. Capital expenditures for the full year are expected to be slightly below 1995 levels due to the divestiture.
- Legal Proceedings: An administrative proceeding with the U.S. EPA regarding a potential penalty is ongoing. The proposed penalty was amended to $957,225. The Company is negotiating a settlement, but terms and timing are uncertain.
- Environmental Risks: The Company is subject to federal and state environmental laws, including the Superfund law, which may result in liability for hazardous waste site cleanup costs.
Investor Verification Checklist
- Recurring Earnings: Verify the sustainability of earnings by excluding the $158.2 million one-time gain on the sale of the Olefins Business.
- Share Count Impact: Confirm the impact of the 9.5 million share repurchase (completed April 1, 1996) on future earnings per share calculations, as this is not reflected in the Q1 1996 EPS.
- Environmental Liability: Monitor the status of the EPA settlement negotiations and potential future costs related to hazardous waste sites.
- Operational Performance: Assess the 3% organic sales growth in remaining businesses (bromine, specialty chemicals) to validate the strategic shift away from olefins.